Podcast Highlights

Choosing Wisely: Capitalizing on Atopic Dermatitis Clinical Trial Data for Meaningful Selection of Topical Agents

By March 11, 2020 No Comments

We are finally getting what we asked for: Pharma is ponying up for head to head studies to provide us with meaningful data to help make better clinical decisions. However, these valuable projects are often with systemic agents, such as biologics, leaving topical treatments in the dust.

To address this, Dr. Lawrence Eichenfield, Professor of Dermatology and Pediatrics, UCSD, and colleagues sought to make the most out of the data we do have on the litany of topical options for atopic dermatitis and provide efficacy and safety guidance (A for effort!).

Tune in to hear what this dream team concocted about creams. Hear how an expert approaches new atopic dermatitis patients. Don’t miss out – this is all very topical.

Listen Now

You May Also Like

Podcast Highlights
March 19, 2020

What Women Don’t Want … Psoriasis

In this edition of the JDD Podcast, Dr. Adam Friedman is joined by Dr. Deirdre Hooper, Associate Clinical Professor in the Department of Dermatology at both Louisiana State University and…
Podcast Highlights
March 11, 2020

Choosing Wisely: Capitalizing on Atopic Dermatitis Clinical Trial Data for Meaningful Selection of Topical Agents

CME Available We are finally getting what we asked for: Pharma is ponying up for head to head studies to provide us with meaningful data to help make better clinical…
Podcast Highlights
January 29, 2020

Tapping Tattoo Artists as a Unique Approach to Disseminating Photoprotection Education

CME Available Continued efforts by the dermatology community to educate the public on both photoprotective measures and early skin cancer detection through surveillance has made a significant impact but the…